BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tong AK, Kao YH, Too CW, Chin KF, Ng DC, Chow PK. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. Br J Radiol 2016;89:20150943. [PMID: 26943239 DOI: 10.1259/bjr.20150943] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Plachouris D, Tzolas I, Gatos I, Papadimitroulas P, Spyridonidis T, Apostolopoulos D, Papathanasiou N, Visvikis D, Plachouri KM, Hazle JD, Kagadis GC. A deep-learning-based prediction model for the biodistribution of 90 Y microspheres in liver radioembolization. Med Phys 2021;48:7427-38. [PMID: 34628667 DOI: 10.1002/mp.15270] [Reference Citation Analysis]
2 Powerski M, Bascik B, Omari J, El-sanosy S, Grosser OS, Seidensticker M, Fischbach F, Pech M. Angiographic Anatomy and Relevance of 3 and 9 O’clock Arteries During Radioembolization. Cardiovasc Intervent Radiol 2018;41:890-7. [DOI: 10.1007/s00270-017-1873-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Venkatanarasimha N, Gogna A, Tong KTA, Damodharan K, Chow PKH, Lo RHG, Chandramohan S. Radioembolisation of hepatocellular carcinoma: a primer. Clin Radiol. 2017;72:1002-1013. [PMID: 29032802 DOI: 10.1016/j.crad.2017.07.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
4 van Roekel C, Harlianto NI, Braat AJAT, Prince JF, van den Hoven AF, Bruijnen RCG, Lam MGEH, Smits MLJ. Evaluation of the Safety and Feasibility of Same-Day Holmium-166 -Radioembolization Simulation and Treatment of Hepatic Metastases. J Vasc Interv Radiol 2020;31:1593-9. [PMID: 32861571 DOI: 10.1016/j.jvir.2020.01.032] [Reference Citation Analysis]
5 Devulapalli KK, Fidelman N, Soulen MC, Miller M, Johnson MS, Addo E, El-haddad G, Nutting C, Morrison J, Farsad K, Lokken RP, Gaba RC, Fleming J, Brown DB, Kwan SW, Rose SC, Pennycooke KA, Liu DM, White SB, Gandhi R, Lazar AA, Kerlan RK. 90 Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections. Radiology 2018;288:774-81. [DOI: 10.1148/radiol.2018170962] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
6 Cazzato RL, Hubelé F, De Marini P, Ouvrard E, Salvadori J, Addeo P, Garnon J, Kurtz JE, Greget M, Mertz L, Goichot B, Gangi A, Imperiale A. Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures. Cancers (Basel) 2021;13:6368. [PMID: 34944988 DOI: 10.3390/cancers13246368] [Reference Citation Analysis]
7 Filippi L, Di Costanzo GG, Tortora R, Pelle G, Cianni R, Schillaci O, Bagni O. Repeated Treatment with 90 Y-Microspheres in Intrahepatic Cholangiocarcinoma Relapsed After the First Radioembolization. Cancer Biotherapy and Radiopharmaceuticals 2019;34:231-7. [DOI: 10.1089/cbr.2018.2718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Depalo T, Traino AC, Bargellini I, Lorenzoni G, Bozzi E, Vivaldi C, Lamastra R, Masi G, Cioni R, Boni G, Volterrani D. Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres. Sci Rep 2021;11:19745. [PMID: 34611210 DOI: 10.1038/s41598-021-99219-7] [Reference Citation Analysis]
9 Biondetti P, Saggiante L, Ierardi AM, Iavarone M, Sangiovanni A, Pesapane F, Fumarola EM, Lampertico P, Carrafiello G. Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC. Cancers (Basel) 2021;13:5797. [PMID: 34830949 DOI: 10.3390/cancers13225797] [Reference Citation Analysis]
10 Fisher DR. Radiation Safety for Yttrium-90-polymer Composites (RadioGel™) in Therapy of Solid Tumors. Health Phys 2021;120:510-6. [PMID: 33760767 DOI: 10.1097/HP.0000000000001369] [Reference Citation Analysis]
11 Goh WXT, Leong S, Too CW, Cheng LT, Saffari SE, Lee RZ, Ng STS, Lo RHG, Tay KH, Chan SXJM, Gogna A, Irani FG, Venkatanarasimha N, Loke KSH, Chow PKH, Ng DCE, Urlings TAJ, Patel A, Damodharan K, Toh LHW, Tan BS. Catheter-Directed Computed Tomography Hepatic Angiography for Yttrium-90 Selective Internal Radiotherapy of Hepatocellular Carcinoma Reduces Prophylactic Embolization of Extrahepatic Vessels. Cardiovasc Intervent Radiol 2020;43:478-87. [PMID: 31705243 DOI: 10.1007/s00270-019-02362-y] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Chaichana A, Frey EC, Teyateeti A, Rhoongsittichai K, Tocharoenchai C, Pusuwan P, Jangpatarapongsa K. Automated segmentation of lung, liver, and liver tumors from Tc-99m MAA SPECT/CT images for Y-90 radioembolization using convolutional neural networks. Med Phys 2021. [PMID: 34657293 DOI: 10.1002/mp.15303] [Reference Citation Analysis]
13 Badar W, Van Ha T, Zangan S, Navuluri R, Pillai A, Baker T, Dalag L, Han R, Ahmed O. Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory. Br J Radiol 2021;94:20200752. [PMID: 33411569 DOI: 10.1259/bjr.20200752] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Dickinson NJ, Kalirai C, O'Connor RA, Mullin K. Hepatic selective internal radiation therapy: how well does pretreatment 99mTc-macroaggregated albumin activity distribution and quantification agree with post-therapy bremsstrahlung imaging? Nucl Med Commun 2018;39:809-17. [PMID: 29879091 DOI: 10.1097/MNM.0000000000000872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Pandey U, Subramanian S, Shaikh S, Gamre N, Kumar S, Dash A. Synthesis and Preliminary Biological Evaluation of 177Lu-Labeled Polyhydroxamic Acid Microparticles Toward Therapy of Hepatocellular Carcinoma. Cancer Biother Radiopharm 2019;34:306-15. [PMID: 31188652 DOI: 10.1089/cbr.2018.2747] [Reference Citation Analysis]
16 Law M, Wong KK, Tso WK, Lee V, Luk MY, Tong CC, Chu F. Personnel dose reduction in 90Y microspheres liver-directed radioembolization: from interventional radiology suite to patient ward. Br J Radiol 2017;90:20160591. [PMID: 27993095 DOI: 10.1259/bjr.20160591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Walrand S, Hesse M, Jamar F. Update on novel trends in PET/CT technology and its clinical applications. Br J Radiol 2018;91:20160534. [PMID: 27730823 DOI: 10.1259/bjr.20160534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Martin M, Hocquelet A, Debordeaux F, Bordenave L, Blanc JF, Papadopoulos P, Lapuyade B, Trillaud H, Pinaquy JB. Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres. Diagn Interv Imaging 2021;102:45-52. [PMID: 33032960 DOI: 10.1016/j.diii.2020.09.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Tong AK, Tham WY, Too CW, Tai DW, Chow PK, Ng DC. Molecular Imaging and Therapy of Liver Tumors. Semin Nucl Med 2020;50:419-33. [PMID: 32768006 DOI: 10.1053/j.semnuclmed.2020.04.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Sebastian NT, Tan Y, Miller ED, Williams TM, Alexandra Diaz D. Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma. Clin Transl Radiat Oncol 2019;19:66-71. [PMID: 31517072 DOI: 10.1016/j.ctro.2019.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Qian Y, Liu Q, Li P, Han Y, Zhang J, Xu J, Sun J, Wu A, Song S, Lu W. Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization. ACS Nano 2021;15:2933-46. [PMID: 33529007 DOI: 10.1021/acsnano.0c09122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Villalobos A, Soliman MM, Majdalany BS, Schuster DM, Galt J, Bercu ZL, Kokabi N. Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know. Semin Intervent Radiol 2020;37:543-54. [PMID: 33328711 DOI: 10.1055/s-0040-1720954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chan KT, Alessio AM, Johnson GE, Vaidya S, Kwan SW, Monsky W, Wilson AE, Lewis DH, Padia SA. Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2018;101:358-65. [DOI: 10.1016/j.ijrobp.2018.01.116] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
24 Gallio E, Richetta E, Finessi M, Stasi M, Pellerito RE, Bisi G, Ropolo R. Calculation of tumour and normal tissue biological effective dose in 90 Y liver radioembolization with different dosimetric methods. Physica Medica 2016;32:1738-44. [DOI: 10.1016/j.ejmp.2016.10.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Morán V, Prieto E, Sancho L, Rodríguez-Fraile M, Soria L, Zubiria A, Martí-Climent JM. Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods? EJNMMI Phys 2020;7:72. [PMID: 33284389 DOI: 10.1186/s40658-020-00343-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Anh LT, Cuong PV, Ha NH, Thao HT. Intercomparison of Geant4 low energy electromagnetic models in 90Y dosimetry. Appl Radiat Isot 2021;178:109938. [PMID: 34560513 DOI: 10.1016/j.apradiso.2021.109938] [Reference Citation Analysis]
27 Abbott EM, Falzone N, Lee BQ, Kartsonaki C, Winter H, Greenhalgh TA, McGowan DR, Syed N, Denis-Bacelar AM, Boardman P, Sharma RA, Vallis KA. The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of 90Y SIRT in Colorectal Cancer Patients. J Nucl Med 2020;61:1658-64. [PMID: 32358093 DOI: 10.2967/jnumed.119.233650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
28 Goh WXT, Too CW, Lee KA, Tan BS, Tay KH, Chandramohan S, Lo RHG, Irani FG, Venkatanarasimha N, Damodharan K, Kumar KKP, Zhuang KD, Chua JME, Bangaragiri A, Leong S. Management of arterial dissections in 12 patients during transarterial chemoembolization and yttrium-90 selective internal radiotherapy for primary and secondary liver tumours. Abdom Radiol (NY) 2021;46:1737-45. [PMID: 33052468 DOI: 10.1007/s00261-020-02810-1] [Reference Citation Analysis]
29 Tafti BA, Padia SA. Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET. Semin Nucl Med 2019;49:211-7. [PMID: 30954187 DOI: 10.1053/j.semnuclmed.2019.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
30 Bastiaannet R, Kappadath SC, Kunnen B, Braat AJAT, Lam MGEH, de Jong HWAM. The physics of radioembolization. EJNMMI Phys 2018;5:22. [PMID: 30386924 DOI: 10.1186/s40658-018-0221-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
31 Sapienza MT, Willegaignon J. Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning. Clinics (Sao Paulo) 2019;74:e835. [PMID: 31365617 DOI: 10.6061/clinics/2019/e835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
32 Costa PF, Testanera G, Camoni L, Terwinghe C, Bailey EA, Bolus NE, Alden TM; EANM Technologist Committee., on behalf of the ANZSNM Technologists Special Interest Group., on behalf of the SNMMI Technologist Section., CAMRT. Technologist Approach to Global Dose Optimization. J Nucl Med Technol 2019;47:75-82. [PMID: 30413598 DOI: 10.2967/jnmt.118.218131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Yacoub JH, Mauro D, Moon A, He AR, Bashir MR, Hsu CC, Fishbein TM, Burke LMB. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention. Abdom Radiol (NY) 2021;46:3540-8. [PMID: 33864107 DOI: 10.1007/s00261-021-03074-z] [Reference Citation Analysis]
34 Plachouris D, Mountris KA, Papadimitroulas P, Spyridonidis T, Katsanos K, Apostolopoulos D, Papathanasiou N, Hazle JD, Visvikis D, Kagadis GC. Clinical Evaluation of a Three-Dimensional Internal Dosimetry Technique for Liver Radioembolization with 90Y Microspheres Using Dose Voxel Kernels. Cancer Biother Radiopharm 2021. [PMID: 33656372 DOI: 10.1089/cbr.2020.4554] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Zubiri L, Bilbao JI, Rodríguez J, Sangro B. Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors. Hepat Oncol 2018;5:HEP09. [PMID: 31293777 DOI: 10.2217/hep-2017-0025] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Rashid NS, Grible JM, Clevenger CV, Harrell JC. Breast cancer liver metastasis: current and future treatment approaches. Clin Exp Metastasis 2021;38:263-77. [PMID: 33675501 DOI: 10.1007/s10585-021-10080-4] [Reference Citation Analysis]
37 Sayan M, Yegya-Raman N, Greco SH, Gui B, Zhang A, Chundury A, Grandhi MS, Hochster HS, Kennedy TJ, Langan RC, Malhotra U, Rustgi VK, Shah MM, Spencer KR, Carpizo DR, Nosher JL, Jabbour SK. Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes. Front Oncol 2019;9:345. [PMID: 31275846 DOI: 10.3389/fonc.2019.00345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
38 Calvo A, Tabone M, Carbonatto P, Richetta E, Pellerito R. Radioembolization in a Single Session Using 90-Yttrium Resin Microspheres. J Vasc Interv Radiol. 2019;30:1648-1649. [PMID: 31514998 DOI: 10.1016/j.jvir.2019.06.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Chiesa C, Strigari L, Pacilio M, Richetta E, Cannatà V, Stasi M, Marzola MC, Schillaci O, Bagni O, Maccauro M. Dosimetric optimization of nuclear medicine therapy based on the Council Directive 2013/59/EURATOM and the Italian law N. 101/2020. Position paper and recommendations by the Italian National Associations of Medical Physics (AIFM) and Nuclear Medicine (AIMN). Phys Med 2021;89:317-26. [PMID: 34583307 DOI: 10.1016/j.ejmp.2021.07.001] [Reference Citation Analysis]
40 Webster LA, Villalobos A, Majdalany BS, Bercu ZL, Gandhi RT, Kokabi N. Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know. Semin Intervent Radiol 2021;38:405-11. [PMID: 34629706 DOI: 10.1055/s-0041-1732323] [Reference Citation Analysis]
41 d’Abadie P, Walrand S, Lhommel R, Hesse M, Borbath I, Jamar F. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology 2022;29:2422-34. [DOI: 10.3390/curroncol29040196] [Reference Citation Analysis]